NeuroVia Alternatives & Competitors
12 companies similar to NeuroVia — Dedicated to halting the progression of severe neurological disorders and improv...
Companies similar to NeuroVia
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Polaryx Therapeutics
Clinical-stage biotech developing patient-friendly drug candidates for the treatment of ly...
Paramus, United States
Track all NeuroVia competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
RiMO Therapeutics
Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce...
AGY Therapeutics
Pioneering breakthrough treatments for central nervous system diseases through innovative...
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Bresso, Italy
Aptinyx Inc.
Innovative therapies for disorders of the brain and nervous system
Evanston, United States
Mosanna Therapeutics
A Swiss Biotech company with a commitment to improving patient outcomes and quality of lif...
Basel, Switzerland
Y-mAbs Therapeutics, Inc.
Innovative pediatric immunotherapies for Real-life Possibilities
New York, United States
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
Mitochon Pharmaceuticals, Inc.
Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegener...
United States
About NeuroVia
NeuroVia is a biopharmaceutical and biotechnology startup dedicated to halting the progression of severe neurological disorders and improving patient outcomes. Founded in 2013, the company is committed to addressing unmet medical needs in neurological diseases, with the primary goal of arresting the onset of devastatin...
Neurological Disorders, Patient Outcomes, Neurological Diseases, X-ALD, Medical Needs, Neurological Deficits, Disease Progression, Treatment Development, Innovative Therapies
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NeuroVia and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NeuroVia on 11 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
